Revenue | ₹47.64Cr |
Net Profits | ₹10.16Cr |
Net Profit Margins | 21.33% |
Jenburkt Pharmaceuticals Ltd’s revenue jumped 10.61% since last year same period to ₹47.64Cr in the Q2 2025-2026. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 26.77% jump in its revenue since last 3-months.
Jenburkt Pharmaceuticals Ltd’s net profit jumped 5.83% since last year same period to ₹10.16Cr in the Q2 2025-2026. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 30.42% jump in its net profits since last 3-months.
Jenburkt Pharmaceuticals Ltd’s net profit margin fell -4.32% since last year same period to 21.33% in the Q2 2025-2026. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 2.88% jumped in its net profit margins since last 3-months.
The revenue for Jenburkt Pharmaceuticals Ltd in the Q2 results 2025 was ₹47.64Cr.
The net profit for Jenburkt Pharmaceuticals Ltd in the Q2 results 2025 was ₹10.16Cr.
The net profit margin for Jenburkt Pharmaceuticals Ltd in the Q2 results 2025 was 21.33%.
The revenue for Jenburkt Pharmaceuticals Ltd in the Q2 results 2024 was ₹43.07Cr.
The net profit for Jenburkt Pharmaceuticals Ltd in the Q2 results 2024 was ₹9.60Cr.
The net profit margin for Jenburkt Pharmaceuticals Ltd in the Q2 results 2024 was 22.29%.